<h1>Bloomage Achieves GMP Certification from South Korea's MFDS, Strengthening Global Presence in Bioactive Solutions</h1> Bloomage, a leader in bioactive innovations, has passed a GMP audit by South Korea's Ministry of Food and Drug Safety (MFDS) with no compliance issues. This achievement underscores Bloomage's dedication to quality assurance in pharmaceutical-grade products, meeting South Korea's strict regulatory standards. The audit assessed systems like quality and production management. As a result, Bloomage can supply GMP-certified Sodium Hyaluronate to Korean pharmaceutical manufacturers. The company has also passed audits by the US FDA, Japan PMDA, and China NMPA, highlighting its industry-leading quality management. Bloomage aims to expand its presence in South Korea and continue delivering innovative bioactive solutions globally.